SCIAMPA M 12.5mg + 500mg Tablet by Scilife Pharma is a combination therapy designed for adults with Type 2 Diabetes Mellitus who require effective blood sugar control. This tablet combines:
By targeting blood glucose through two complementary mechanisms, SCIAMPA M 12.5mg + 500mg provides superior glycemic control while improving heart, kidney, and metabolic health.
Empagliflozin reduces the risk of:
Slows the progression of diabetic nephropathy by reducing kidney strain and glucose load.
Reduces pill burden by combining two medications in one, improving adherence and simplifying diabetes management.
Doctors prescribe SCIAMPA M 12.5mg + 500mg Tablet for:
Not recommended for:
Possible mild side effects include:
Seek immediate medical attention for:
⭐⭐⭐⭐⭐ “Dual-action tablet is very effective. Blood sugar is stable, and it’s easy to take once daily.” – Sana, Lahore
⭐⭐⭐⭐⭐ “Good combination medicine for diabetes. Works well and authentic product.” – Imran, Karachi
